Skip to main content

MoneyWorks4Me

Lupin informs about earnings conference call transcript

25 May 2021 Evaluate

Pursuant to Regulation 30(2) read with Schedule III Part A Para A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Transcript of the Q4 FY2021 Earnings Conference Call held on Thursday, May 13, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..